Jeff Smith serves as a program advisor within the Malaria Vaccine Initiative and the Center for Vaccine Innovation and Access (CVIA). Jeff brings a strong background in monoclonal antibodies (mAbs) and drug development to MVI. Jeff will be the scientific lead on project teams working to bring first generation anti-infection and transmission-blocking mAbs to clinical testing. He will also lead the effort to identify configurations of these antibodies suitable for development as malaria elimination campaigns.
Before joining PATH, Jeff worked at Medimmune, where he was responsible for several early and late stage mAb development projects.